Epilepsy drugs can bring suicide risk according to Food & Drug Administration.
FDA with the association of manufacturers will the working on including this new information in the labeling for these products and that way they will appear on the market,” says the US drug safety regulator.
On Friday, the US drug safety regulator informed that the anti-epileptic drugs used to cure migraine headaches, epilepsy and other conditions carry a risk of suicidal behavior and thoughts.
Related posts:
- Under The FDA safety review will be The Pfizer anti-smoking drug
- FDA Makes Public Announcements About Adverse Reactions Linked to Botox Use
- Diabetes Drug Byetta could bring Pancreas Risk?
- Nexium was Approved by FDA for Use in Children Ages 1-11 Years
- FDA Panel Backs Tougher Warning for Tamiflu
